MRK ▼ -0.4% - Merck & Co., Inc.
$MRK - Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026
13-OCT-2026 06:53 AM ET
Share this post
More filings for $MRK
MRK ▲ +2.8% - Merck & Co., Inc.Oct 10, 2026MRK ▲ +0.3% - Merck & Co., Inc.Sep 30, 2026MRK ▲ +0.3% - Merck & Co., Inc.Sep 30, 2026MRK ▲ +0.1% - Merck & Co., Inc.Sep 28, 2026MRK ▲ +0.4% - Merck & Co., Inc.Sep 25, 2026MRK ▲ +0.2% - Merck & Co., Inc.Sep 22, 2026
View full $MRK filing history →💬 Comments
Loading comments…
Leave a comment